title: [Occurrence of peripheral edema in a switch from buprenorphine alone to the buprenorphine-naloxone combination: About one case].
authors.affiliation: Service pharmacie clinique, établissement public de santé Alsace-Nord, 141, avenue de Strasbourg, 67170 Brumath, France. Electronic address: herve.javelot@ch-epsan.fr.
authors.forename: Hervé
authors.initials: H
authors.lastname: Javelot
authors.affiliation: Service G04, établissement public de santé Alsace Nord, 67170 Brumath, France.
authors.forename: Thierry
authors.initials: T
authors.lastname: Royer
authors.affiliation: Équipe de liaison et de soins en addictologie, centre hospitalier Saint-Jean-de-Dieu, 69008 Lyon, France.
authors.forename: Thierry
authors.initials: T
authors.lastname: Javelot
authors.affiliation: Centre régional de pharmacovigilance, CHU de Strasbourg, 67000 Strasbourg, France.
authors.forename: Charlotte
authors.initials: C
authors.lastname: Muller
authors.affiliation: Centre régional de pharmacovigilance, CHU de Strasbourg, 67000 Strasbourg, France.
authors.forename: Martine
authors.initials: M
authors.lastname: Tebacher
mesh_terms: D000328:Adult; D002047:Buprenorphine / Q000627:therapeutic use*; D000069479:Buprenorphine, Naloxone Drug Combination / Q000008:administration & dosage / Q000009:adverse effects*; D057915:Drug Substitution / Q000009:adverse effects*; D004487:Edema / Q000139:chemically induced*; D006225:Hand; D006801:Humans; D008297:Male; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D058850:Opiate Substitution Treatment / Q000379:methods
chemical_list: D000069479:Buprenorphine, Naloxone Drug Combination; D009292:Narcotic Antagonists; D002047:Buprenorphine
keywords: Buprenorphine–naloxone combination; Combinaison buprénorphine–naloxone; Pruritic erythematous edema; Œdème érythémateux et prurigineux